Literature DB >> 16023747

Brain natriuretic peptide based strategy to detect left ventricular dysfunction in Chagas disease: a comparison with the conventional approach.

Antonio Luiz P Ribeiro1, Mauro M Teixeira, Adelina M Reis, Andre Talvani, Amanda A Perez, Márcio Vinicius L Barros, Manoel Otávio C Rocha.   

Abstract

BACKGROUND: Left ventricular dysfunction (LVd) is the main predictor of mortality in Chagas disease (ChD). AIMS: To compare the diagnostic performance of the conventional approach (ECG and chest X-ray) in the recognition of LVd in ChD, with a new strategy, in which BNP is measured in patients with an abnormal ECG.
METHODS: Consecutive ChD patients recruited at an Outpatient Reference Center in Belo Horizonte, Brazil, without other systemic diseases, in 1998-99 (sample 1, n = 165) and in 2001-02 (sample 2, n = 62) underwent ECG, chest X-ray, BNP measurement and echocardiography.
RESULTS: The prevalence of LVd (ejection fraction <or=0.40) was 9.1% in the sample 1. The conventional strategy recognized all patients with LVd (sensitivity: 100%, 95% CI: 79.6-100% and negative predictive value -PV 100%, 92.1-100%), but with low specificity (30%, 95% CI: 23.2-37.8) and +PV (12.5%, 95% IC: I7.7-19.6). The BNP/ECG strategy showed significantly better specificity (96.0%, 95% CI: 91.5-98.2, p < 0.001) and +PV (66.7%, 95% CI: 43.7-83.7, p < 0.001), and non-significantly lower sensitivity (80.0%, 95% CI: 54.8-93.0, p = 0.25) and -PV (98.0%,95% CI: 94.2-99.3, p = 0.08). Overall accuracy was improved with the new strategy. (94.5%,95% CI: 90.0-97.1 x 36.4%, 95% CI: 29.4-43.9, p < 0.001). Similar results were obtained for the sample 2.
CONCLUSIONS: The BNP-based strategy was more accurate than the conventional approach in the detection of LVd in ChD patients and should be considered as a valid option.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16023747     DOI: 10.1016/j.ijcard.2005.05.048

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  11 in total

Review 1.  Chagas heart disease: report on recent developments.

Authors:  Fabiana S Machado; Linda A Jelicks; Louis V Kirchhoff; Jamshid Shirani; Fnu Nagajyothi; Shankar Mukherjee; Randin Nelson; Christina M Coyle; David C Spray; Antonio C Campos de Carvalho; Fangxia Guan; Cibele M Prado; Michael P Lisanti; Louis M Weiss; Susan P Montgomery; Herbert B Tanowitz
Journal:  Cardiol Rev       Date:  2012 Mar-Apr       Impact factor: 2.644

2.  Inflammatory and cardiac biomarkers are differentially expressed in clinical stages of Chagas disease.

Authors:  S M Keating; X Deng; F Fernandes; E Cunha-Neto; A L Ribeiro; B Adesina; A I Beyer; P Contestable; B Custer; M P Busch; E C Sabino
Journal:  Int J Cardiol       Date:  2015-07-12       Impact factor: 4.164

Review 3.  Chronic Chagas' heart disease: a disease on its way to becoming a worldwide health problem: epidemiology, etiopathology, treatment, pathogenesis and laboratory medicine.

Authors:  Silvia Gilka Muñoz-Saravia; Annekathrin Haberland; Gerd Wallukat; Ingolf Schimke
Journal:  Heart Fail Rev       Date:  2012-01       Impact factor: 4.214

Review 4.  Diagnosis and management of Chagas disease and cardiomyopathy.

Authors:  Antonio L Ribeiro; Maria P Nunes; Mauro M Teixeira; Manoel O C Rocha
Journal:  Nat Rev Cardiol       Date:  2012-07-31       Impact factor: 32.419

Review 5.  Perspectives on Trypanosoma cruzi-induced heart disease (Chagas disease).

Authors:  Herbert B Tanowitz; Fabiana S Machado; Linda A Jelicks; Jamshid Shirani; Antonio C Campos de Carvalho; David C Spray; Stephen M Factor; Louis V Kirchhoff; Louis M Weiss
Journal:  Prog Cardiovasc Dis       Date:  2009 May-Jun       Impact factor: 8.194

6.  Chagas cardiomyopathy: the potential of diastolic dysfunction and brain natriuretic peptide in the early identification of cardiac damage.

Authors:  Ana Garcia-Alvarez; Marta Sitges; María-Jesús Pinazo; Ander Regueiro-Cueva; Elizabeth Posada; Silvia Poyatos; José Tomás Ortiz-Pérez; Magda Heras; Manel Azqueta; Joaquim Gascon; Ginés Sanz
Journal:  PLoS Negl Trop Dis       Date:  2010-09-21

7.  Biomarkers in Trypanosoma cruzi-infected and uninfected individuals with varying severity of cardiomyopathy in Santa Cruz, Bolivia.

Authors:  Emi E Okamoto; Jacqueline E Sherbuk; Eva H Clark; Morgan A Marks; Omar Gandarilla; Gerson Galdos-Cardenas; Angel Vasquez-Villar; Jeong Choi; Thomas C Crawford; Rose Q Do; Rose Q; Antonio B Fernandez; Rony Colanzi; Jorge Luis Flores-Franco; Robert H Gilman; Caryn Bern
Journal:  PLoS Negl Trop Dis       Date:  2014-10-02

8.  Electrocardiographic abnormalities in Trypanosoma cruzi seropositive and seronegative former blood donors.

Authors:  Antonio L Ribeiro; Ester C Sabino; Milena S Marcolino; Vera M C Salemi; Barbara M Ianni; Fábio Fernandes; Luciano Nastari; André Antunes; Márcia Menezes; Cláudia Di Lorenzo Oliveira; Vandana Sachdev; Danielle M Carrick; Michael P Busch; Eduard L Murphy
Journal:  PLoS Negl Trop Dis       Date:  2013-02-28

9.  Electrocardiographic abnormalities in elderly Chagas disease patients: 10-year follow-up of the Bambui Cohort Study of Aging.

Authors:  Antonio Luiz P Ribeiro; Milena S Marcolino; Ronald J Prineas; Maria Fernanda Lima-Costa
Journal:  J Am Heart Assoc       Date:  2014-02-07       Impact factor: 5.501

10.  Left ventricular systolic dysfunction predicted by artificial intelligence using the electrocardiogram in Chagas disease patients-The SaMi-Trop cohort.

Authors:  Bruno Oliveira de Figueiredo Brito; Zachi I Attia; Larissa Natany A Martins; Pablo Perel; Maria Carmo P Nunes; Ester Cerdeira Sabino; Clareci Silva Cardoso; Ariela Mota Ferreira; Paulo R Gomes; Antonio Luiz Pinho Ribeiro; Francisco Lopez-Jimenez
Journal:  PLoS Negl Trop Dis       Date:  2021-12-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.